Impaired fear memory specificity associated with deficient endocannabinoid-dependent long-term plasticity

Neuropsychopharmacology

Volumn 39, Issue 7, 2014, Pages 1685-1693

  Lovelace, Jonathan W ^a   Vieira, Philip A ^a   Corches, Alex ^a   Mackie, Ken ^b   Korzus, Edward ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

endocannabinoid system; memory specificity; NMDA receptor; pattern separation; schizophrenia; synaptic plasticity

Indexed keywords

ENDOCANNABINOID; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; AMINO ACID; AMINO ACID RECEPTOR BLOCKING AGENT; AMINO ACID RECEPTOR STIMULATING AGENT; ENZYME INHIBITOR; FUSED HETEROCYCLIC RINGS; PHENCYCLIDINE;

ADULT; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; BRAIN DEVELOPMENT; COGNITION; CONTROLLED STUDY; EPISODIC MEMORY; FEMALE; INFANT; LOCOMOTION; LONG TERM DEPRESSION; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; ANIMAL; BRAIN; C57BL MOUSE; CHEMICALLY INDUCED; CONDITIONING; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; FEAR; LONG TERM POTENTIATION; MEMORY DISORDER; METABOLISM; NERVE CELL; NEWBORN; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TOXICITY;

AMINO ACIDS; ANIMALS; ANIMALS, NEWBORN; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEAR; FEMALE; LONG-TERM POTENTIATION; LONG-TERM SYNAPTIC DEPRESSION; MALE; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; NEURONS; PHENCYCLIDINE; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION;

EID: 84900533884     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.15     Document Type: Article

References (49)

1. Best AR, Regehr WG (2008). Serotonin evokes endocannabinoid release and retrograDely suppresses excitatory synapses. J Neurosci 28: 6508-6515.
2. Calabresi P, Maj R, Pisani A, Mercuri NB, Bernardi G (1992). Longterm synaptic Depression in the striatum: Physiological and pharmacological characterization. J Neurosci 12: 4224-4233.
3. Caspi A,Moffitt TE,Cannon M,Mc Clay J,Murray R,Harrington H,et al,2005, MoDeration of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal eviDence of a gene-environment interaction, Biol Psychiatry,57, 1117-1127.
4. Chen K, Ratzliff A, Hilgenberg L, Gulyas A, Freund TF, Smit h M et al (2003). Long-term plasticity of endocannabinoid signaling induced by Developmental febrile seizures. Neuron 39: 599-611.
5. Coyle JT, Tsai G, Goff D (2003). Converging eviDence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann N Y Acad Sci 1003: 318-327.
6. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC et al (1994). Formation and inactivation of endogenous cannabinoid anandamiDe in central neurons. Nature 372: 686-691.
7. GerDeman GL, Ronesi J, Lovinger DM (2002). Postsynaptic endocannabinoid release is critical to long-term Depression in the striatum. Nat Neurosci 5: 446-451.
8. Grayson B, Idris NF, Neill JC (2007). Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive Deficit in the novel object recognition task in the rat. Behav Brain Res 184: 31-38.
9. Haller J, Szirmai M, Varga B, LeDent C, Freund TF (2005). Cannabinoid CB1 receptor DepenDent effects of the NMDA antagonist phencyclidine in the social withdrawal m oDel of schizophrenia. Behav Pharmacol 16: 415-422.
10. Hempel CM, Hartman KH, Wang XJ, Turrigiano GG, Nelson SB (2000). Multiple forms of short-term plasticity at excitatory synapses in rat medial pref rontal cortex. J Neurophysiol 83: 3031-3041.
11. Hsieh C, Brown S, Derleth C, Mackie K (1999). Internalization and recycling of the CB1 cannabinoid receptor. J Neurochem 73: 493-501.
12. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine moDel of schizophrenia. Am J Psychiatry 148: 1301-1308.
13. Kasanetz F, LafourcaDe M, Deroche-Gamonet V, Revest JM, Berson N, Balado E et al (2012). Prefrontal synaptic markers of cocaine addiction-like behavior in rats. Mol Psychiatry 18: 729-737.
14. Kim J, Isokawa M, LeDent C, Alger BE (2002). Activation of musc arinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 22: 10182-10191.
15. Korzus E, Rosenfeld MG, Mayford M (2004). CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 42: 961-972.
16. Kreitzer AC, Malenka RC (2007). Endocannabinoid-mediated rescue of striatal LTD and motor Deficits in Parkinson?s disease moDels. Nature 445: 643-647.
17. LafourcaDe M, Elezgarai I, Mato S, Bakiri Y, GranDes P, Manzoni OJ (2007). Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS One 2: E709.
18. Leroy S, Griffon N, BourDel MC, Olie JP, Poirier MF, Krebs MO (2001). Schizophrenia and the cannabinoid receptor type 1 (CB1): Association study using a single-base polymorphism in coding ex on 1. Am J Med Genet 105: 749-752.
19. Leutgeb JK, Leutgeb S, Moser MB, Moser EI (2007). Pattern separation in the Dentate gyrus and CA3 of the hippocampus. Science 315: 961-966.
20. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE et al (2009). Selective blockaDe of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 5: 37-44.
21. Lovinger DM (2008). Presynaptic modulation by endocannabinoids. Handb Exp Pharmacol 184: 435-477.
22. Makara JK, Mor M, Fegley D, Szabo SI, Kathuria S, Astarita G et al (2005 ). Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat Neurosci 8: 1139-1141.
23. Marr D (1971). Simple memory: A theory for archicortex. Philos Trans R Soc Lond Ser B 262: 23-81.
24. Marrs WR,Blankman JL,Horne EA,Thomazeau A,Lin YH,Coy J,et al,2010, The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors, Nat N eurosci,13, 951-957.
25. Mato S, Chevaleyre V, Robbe D, Pazos A, Castillo PE, Manzoni OJ (2004). A single in-vivo exposure to Delta 9THC blocks endocannabinoid-mediated synaptic plasticity. Nat Neur osci 7: 585-586.
26. Mato S, Robbe D, Puente N, GranDes P, Manzoni OJ (2005). Presynaptic homeostatic plasticity rescues long-term Depression after chronic Delta 9-tetrahydrocannabinol exposure. J Neuro sci 25: 11619-11627.
27. McHugh TJ, Jones MW, Quinn JJ, Balthasar N, Coppari R, Elmquist JK et al (2007). Dentate gyrus NMDA receptors mediate rapid pattern separation in the hippocampal network. Science 317: 94-99.
28. Morris BJ, Cochran SM, Pratt JA (2005). PCP: From pharmacology to moDelling schizophrenia. Curr Opin Pharmacol 5: 101-106.
29. Morris SH, Knevett S, Ler ner EG, Bindman LJ (1999). Group I mGluR agonist DHPG facilitates the induction of LTP in rat prelimbic cortex in vitro. J Neurophysiol 82: 1927-1933.
30. Nakatani-Pawlak A, Yamaguchi K, Tatsumi Y, Mizo guchi H, Yoneda Y (2009). Neonatal phencyclidine treatment in mice induces behavioral, histological and neurochemical abnormalities in adulthood. Biol Pharm Bull 32: 1576-1583.
31. Navawongse R, Eichenbaum H (2 013). Distinct pathways for rulebased retrieval and spatial mapping of memory representations in hippocampal neurons. J Neurosci 33: 1002-1013.
32. OReilly RC, McClelland JL (1994). Hippocampal conjunctive encoding, storage, and recall: Avoiding a traDe-off. Hippocampus 4: 661-682.
33. Pelletier M, Achim AM, Montoya A, Lal S, Lepage M (2005). Cognitive and clinical moDerators of recognition memory in schizophrenia: A meta-analysis. Schizophr Res 74: 233-252.
34. Piomelli D (2003). The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884.
35. Reichenberg A, Caspi A, Harrington H, Houts R, Keefe RS, Murray RM et al (2010). Static and dynamic cognitive Deficits in childhood preceding adult schizophrenia: A 30-year study. Am J Psychiatry 167: 160-169.
36. Rinaldi-Carmona M, Le Duigou A, Oustric D, Barth F, Bouaboula M, Carayon P et al (19 98). Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system. J Pharmacol Exp Ther 287: 1038-1047.
37. Robbe D, Alon so G, Chaumont S, Bockaert J, Manzoni OJ (2002). Role of p/q-Ca2+ channels in metabotropic glutamate receptor 2/3-DepenDent presynaptic long-term Depression at nucleus accumbens synapses. J Neurosci 22: 4346-4356.
38. Sahay A, Wilson DA, Hen R (2011). Pattern separation: A common function for new neurons in hippocampus and olfactory bulb. Neuron 70: 582-588.
39. Tamminga CA (1998). Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 12: 21-36.
40. Tamminga CA (2013). Psychosis is emerging as a learning and memory disorDer. Neuropsychopharmacology 38: 247.
41. Tamminga CA, Stan AD, Wagner AD (2010). The hippocampal formation in schizophrenia. Am J Psychiatry 167: 1178-1193.
42. Tulving E (2002). Episodic memory: From mind to brain. Annu Rev Psychol 53: 1-25.
43. Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M et al (2002). CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephr enic schizophrenia. Mol Psychiatry 7: 515-518.
44. Wang C, McInnis J, Ross-Sanchez M, Shinnick-Gallagher P, Wiley JL, Johnson KM (2001). Long-term behavioral and neuroDegenerative effects of perin atal phencyclidine administration: Implications for schizophrenia. Neuroscience 107: 535-550.
45. Wiley JL, Buhler KG, Lavecchia KL, Johnson KM (2003). Pharmacological challenge reveals long-term effects of perinatal phenc yclidine on Delayed spatial alternation in rats. Prog Neuropsychopharmacol Biol Psychiatry 27: 867-873.
46. Xu W,Morishita W,Buckmaster PS,Pang ZP,Malenka RC,Sudhof TC,2012, Distinct neuronal cod ing schemes in memory revealed by selective erasure of fast synchronous synaptic transmission, Neuron,73, 990-1001.
47. Xu W, Sudhof TC (2013). A neural circuit for memory specificity and generalization. Science 339: 1290-1295.
48. Zammit S, Owen MJ, Evans J, Heron J, Lewis G (2011). Cannabis, COMT and psychotic experiences. Br J Psychiatry 199: 380-385.
49. Zhang ZW (2004). Maturation of layer V pyramidal neurons in the rat prefrontal cortex: Intrinsic properties and synaptic function. J Neurophysiol 91: 1171-1182.